Thermal Biofeedback for the Treatment of Diabetic Neuropathy

Sponsor
Northwestern University (Other)
Overall Status
Completed
CT.gov ID
NCT00858351
Collaborator
Insulin Dependent Diabetes Trust (Other), American Pain Society (Other), Rosalind Franklin University of Medicine and Science (Other)
32
2
53

Study Details

Study Description

Brief Summary

The purpose of this study is to examine potential treatment options for a condition in diabetics that causes tingling, pain, and numbness in the hands and /or feet, also known as diabetic peripheral neuropathy.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Thermal Biofeedback Assisted Relaxation
  • Behavioral: Discussion with therapist
N/A

Detailed Description

Participants attend 6 sessions lasting from 35 minutes to 2 hours (depending on the session). Sessions can be scheduled once or twice per week. Sessions involve a walking task, filling out questionnaires, and having temperature of hands and feet monitored. This study involves no drugs, blood draws, or any other invasive procedures. Participants are urged to continue the treatment of diabetes and diabetic neuropathy as directed by their physician for the duration of their involvement with the study. After 3 months, a packet of questionnaires will be mailed with a stamped addressed envelope to be returned.

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
A Placebo-Controlled Trial of Thermal Biofeedback Assisted Relaxation for the Treatment of Diabetic Neuropathy: An Evaluation of Outcomes and Mechanisms
Study Start Date :
Nov 1, 2007
Actual Primary Completion Date :
Oct 1, 2011
Actual Study Completion Date :
Apr 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Thermal Biofeedback Assisted Relaxation

Behavioral: Thermal Biofeedback Assisted Relaxation
6 sessions, 25 minutes in duration of relaxation and imagery training while temperature of hands and feet are recorded.

Active Comparator: Discussion

Behavioral: Discussion with therapist
6 sessions, 25 minutes each, discussing topics with a therapist.

Outcome Measures

Primary Outcome Measures

  1. Subjective Pain [Change in subjective pain rating from baseline to end of intervention]

Secondary Outcome Measures

  1. Perceived Control [Change from mid-intervention (visit 4) to end of intervention]

  2. Temperature [Change within each session and across sessions from baseline to end of intervention]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical Diagnosis of Diabetic Neuropathy in Hands and/or Feet

  • Must have some sensation left in hands and feet

Exclusion Criteria:
  • Any partial or total amputation of an limb or digit

  • Any previous experience with biofeedback

  • Prior treatment for alcohol abuse

  • Severe Psychopathology

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Northwestern University
  • Insulin Dependent Diabetes Trust
  • American Pain Society
  • Rosalind Franklin University of Medicine and Science

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Angela Fidler Pfammatter, PhD, Postdoctoral Fellow, Northwestern University
ClinicalTrials.gov Identifier:
NCT00858351
Other Study ID Numbers:
  • 200.97PY
First Posted:
Mar 9, 2009
Last Update Posted:
Sep 5, 2021
Last Verified:
Aug 1, 2021
Keywords provided by Angela Fidler Pfammatter, PhD, Postdoctoral Fellow, Northwestern University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 5, 2021